Research conducted by The Affiliated Tumor Hospital of Zhengzhou University showed a correlation between the expression of miR-126 and the regulation of critical metastatic molecule ADAM9 (ADAM metallopeptidase domain 9, a component of cell–cell junctions). Here, ADAM9 is linked to neoplasm.